Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SVF plus subcision versus subcision alone for acne scars
IRCT20211121053126N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Dec 2021
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of autologous adipose stromal vascular fraction in acne scar (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Scar size, Neocollagenosis and 2 more. Started Dec 2021; status: completed.
02
Drugs
autologous adipose stromal vascular fraction
03
Conditions
acne scar
Beyond the preview
Go deeper on IRCT20211121053126N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211121053126N1.